HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$5.74
Day range
$5.61 - $6.07
Year range
$1.45 - $10.99
Market cap
420.07M USD
Avg Volume
873.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.91M | -23.40% |
Net income | -20.92M | 19.31% |
Net profit margin | — | — |
Earnings per share | -0.27 | 65.58% |
EBITDA | -22.96M | 15.66% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 181.77M | 49.58% |
Total assets | 268.69M | 82.85% |
Total liabilities | 22.02M | -26.85% |
Total equity | 246.67M | — |
Shares outstanding | 74.09M | — |
Price to book | 1.70 | — |
Return on assets | -28.02% | — |
Return on capital | -30.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -20.92M | 19.31% |
Cash from operations | -20.08M | 29.11% |
Cash from investing | -101.69M | -8.66% |
Cash from financing | 143.77M | 148,318.56% |
Net change in cash | 22.00M | 118.04% |
Free cash flow | -13.23M | 31.16% |
About
Founded
2017
Website
Employees
59
